The occurrence of sustained yawning, uncoupled from sedation but caused by psychotropic medication, has been noted infrequently in the literature. This case report suggests the possibility of an association between imipramine and sustained yawning. Mechanisms of action for this yawning are proposed and a treatment strategy is offered.
Get full access to this article
View all access options for this article.
References
1.
LiptonM. A.DiMascioA.KillamK. F. (eds.), Psychopharmacology: A Generation of Progress, Rover Press, New York, 1978.
2.
SelkurtE. E. (ed.), Physiology, Boston, Little, Brow and Company, 1975.
3.
YamadaF. and FumkawaT., Direct Evidence for Involvement of Dopaminergic Inhibition and Cholinergic Activation in Yawning, Psychopharmacology, 67, pp. 39–43, 1980.
4.
MariniJ. L., Serotonergic and Dopaminergic Effects of Yawning in the Cat, Parmacological and Biochemical Behavior, 15, pp. 711–715, 1981.
5.
RolesonR. D.WigginsW. S., and GilliganB. S., Drug-Induced Yawning Successfully Treated with Pimozide, Archives of Neurology, 36, pp. 253, 1979.
6.
ThalL. J.SharplessN. S., Treatment of Myoclonus with L-5HTP and Carbiclopa: Clinical, Electrophysiological, and Biochemical Observations, Annals of Neurology, 7, pp. 570–576, 1980.
